AI-generated summary
The authors report a randomized, sham-controlled trial of home-based multi-wavelength laser therapy in 30 patients with chronic low back pain, self-treated over 3 weeks. Both the laser and sham groups showed reduced pain scores, and there were no significant differences between groups across outcomes. The study was small and sham-controlled, and the authors call for further research.
- Participants
- 30
- Who or what was studied
- Patients with chronic low back pain
- Wavelengths
- 670, 780, 830, 910 nm
- Limits stated in the abstract
- The abstract reports a small sample of 30 patients and no significant differences between the laser and sham groups across outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670nm, 780nm, 830nm, 910nm
- Power
- 1mW, 2mW, 15mW, 5mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Randomized controlled trial, Control group, Visual analogue scale, Sham, Primary outcome, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.